baber/WOPTO huggingface dataset:
Patent NZ-277533-A (NZ)
Title: Cutter for producing helical vegetable strips, the innermost slitter blade having greater length
Inventor: PENNEY DEREK JOSEPH
IPC: B26D3/22
Filed: 1994-12-21
Abstract: A cutter for cutting helical vegetable strips comprising a circular disk-like plate having an upstream surface and an axis of rotation. The cutter has a knife blade extending radially from the axis of rotation, the blade edge being axially displaced from the upstream surface. The cutter also includes a plurality of slitter blades spaced apart and located at different distances from the axis of rotation and extending substantially perpendicular to the upstream surface. The slitter blades have different lengths and, therefore, extend to different heights above the upstream surface.
Patent NZ-283012-A (NZ)
Title: Building unit; monolithic unit with spaced apart panels for concrete walls, the panels being of expandable polymeric material and including polymeric tie members
Inventor: PRUSS DONALD E
IPC: E04B2/02
Filed: 1995-03-14
Abstract: There is disclosed a monolithic unit having spaced apart panels (12, 14) for concrete walls in which the unit includes in one embodiment tie members (40) having a chemically similar polymeric composition to that of the panels (12, 14) but differing in a physical form. The result is a fusibly connected integral unit.
Patent NZ-301582-A (NZ)
Title: Aqueous rinsing solution containing non-ionic surfactant and a chelating agent
Inventor: BLACK ROBERT H
IPC: C11D3/20
Filed: 1996-01-18
Abstract: The invention relates to a composition for an aqueous rinsing solution for removing deposits from surfaces of showers and the like, and a method of using same without scrubbing or wiping. The composition includes a non-ionic surfactant having an HLB of 13 or less, a chelating agent, and optionally, alcohol and/or ammonium hydroxide and/or morpholine.
Patent NZ-307540-A (NZ)
Title: Pharmaceutical compositions and use of sarcodictyin derivatives to treat cancer
Inventor: BATTISTINI CARLO
IPC: A61K31/335
Filed: 1996-04-23
Abstract: The present invention relates to terpenoidic derivatives, known in the art as Sarcodictyins, for use as therapeutic agents, and to pharmaceutical compositions containing them. In particular, Sarcodictyins can be useful as therapeutic antineoplastic agents in the treatment of cancers in human or animal beings.
Patent NZ-326023-A (NZ)
Title: Reduced respiratory irritation spray bleaching compositions containing a halogen bleach
Inventor: PETRI MARCO
IPC: C11D7/32
Filed: 1996-12-06
Abstract: A sprayable liquid composition packaged in a spray-type dispenser and comprising a halogen bleach and an organic or inorganic derived -NH2 compound which has the effect of reducing irritation of the respiratory system if spray droplets of the composition are inhaled when the composition is sprayed is claimed.
Patent NZ-329463-A (NZ)
Title: Method for control of resistant lepidoptera using flufenoxuron
Inventor: THIENPONT E
IPC: A01M1/20
Filed: 1997-12-22
Abstract: The present invention provides a method for the control of resistant Lepidoptera of the order Olethreutidae which comprises contacting said Lepidoptera, their habitat, breeding area, or food supply with a toxic amount of 1-[4-(2-chloro-a,a,a-trifluoro-p-tolyloxy)-2-flufenoxuron]-3-(2,6-difluorobenzoyl)urea (flufenoxuron). Also provided is a method for the enhanced protection of fruit crops both growing and harvested from the attack and infestation of resistant Lepidoptera. Advantageously, while flufenoxuron of the invention may be employed alone, it may also be used in combination with other biological or chemical pest control agents such as other insecticides, fungicides, herbicides and the like.
Patent NZ-336015-A (NZ)
Title: Miniature valve for filling the reservoir of an apparatus for the transdermal administration of medicine
Inventor: ROSSI CAROLE
IPC: A61M37/00
Filed: 1997-11-20
Abstract: Disclosed is a miniature valve for filling the reservoir of an apparatus for the transdermal administration of a medicine comprising a) a substrate (1), b) a fuel charge (5) arranged on the substrate (1) opposite the passage to be opened through it, c) an electric resistor (2) placed in contact with the fuel charge (5) so that the supply of this resistor (2) with a predetermined electric energy ensures the combustion of the charge (5) and the opening of the passage (8'), by local rupture of said substrate (1) under the pressure of the fuel gases of the charge (5). The device is stated to be useful for filling a medicine reservoir of an apparatus for the transdermal administration of this medicine aided by inophoresis.
Patent NZ-336841-A (NZ)
Title: NADPH and NADH analogs such as 3-acetylpyridine adenine dinucleotide, 3-acetylpyridine-NADH, 3-acetylpyridine-NADPH, 3-pyridinealdehyde adenine dinucleotide for measurement of enzyme activities
Inventor: KAUFMAN RICHARD A
IPC: C07H19/10
Filed: 1998-02-03
Abstract: A diagnostic reagent kit comprising a compound of Formula (I) for measuring enzyme activities and metabolites using NADH and NADPH analogs. The analogs have extended stability in aqueous solutions and can used as replacements for NADH or NADPH cofactors in analytical procedures. Disclosed are kits containing the NADH and NADPH analogs for use in the measurement of ALT activity, AST activity, urea, ammonia, salicylate, triglycerides, pyruvic acid, sorbitol dehydrogenase activity, 5'-nucleotidase activity, creatine kinase activity, 2,3-diphosphoglyceric acid, adenosine 5'-triphosphate, alpha -hydroxybutyrate dehydrogenase activity, lactate dehydrogenase activity and the carbon dioxide content in analytical samples. Wherein; R1 is Formula (II); R2 is an aryl or heteroaryl; Q is C or S; T is O or S; X is H, OR3 or H2PO4, where R3 is H, C1-4alkyl, C1-4haloalkyl, C1-4 substituted alkyl or halogen; Y is O, S or NOH; and Z is H, C1-6alkyl, C1-6haloalkyl substituted alkyl, NHL where L is H, OH or NH2, aryl, aralkyl; except that L is not H when R2 is adenine.
Patent NZ-502567-A (NZ)
Title: Self-emulsifying formulation for lipophilic compounds containing a pyranone and a mixture of monoglycerides and diglycerides
Inventor: MOROZOWICH WALTER
IPC: A61P31/14
Filed: 1998-07-27
Abstract: A pharmaceutical composition comprising: (a) a pyranone compound of formula II or a pharmaceutically acceptable salt thereof as a pharmaceutically active agent; (b) a mixture of diglyceride and monoglyceride in a ratio of 9:1 to 6:4 by weight  wherein the diglyceride and monoglyceride are mono or di unsaturated fatty acid esters of glycerol having 16 to 22 carbons; (c) one or more pharmaceutically acceptable solvents and (d) one or more pharmaceutically acceptable surfactants. In formula II: R1 is H-; R2 is alkyl, phenyl-(CH2)2-, het-SO2NH-(CH2)2-, cyclopropyl-(CH2)2-, F-phenyl-(CH2)2-, het-SO2NH-phenyl- or F3C-(CH2)2- or R1 and R2 taken together are a double bond; R3 is R4-(CH2)n-CH(R5)-, H3C-[O(CH2)2]2-CH2-, phenyl-(CH2)2-, het-SO2NH-(CH2)2-, (HOCH2)3C-NH-C(O)-NH-(CH2)3-, (HO2C)(H2N)CH-(CH2)2-C(O)-NH-(CH2)3-, piperazin-1-yl-C(O)-NH-(CH2)3, HO3S-(CH2)2-N(CH3)-C(O)-(CH2)6-C(O)-NH-(CH2)3-, cyclopropyl-(CH2)2-, F-phenyl-(CH2)2-, het-SO2NH-phenyl, or F3C-(CH2)2-; n is 0, 1 or 2; R4 is phenyl, het, cyclopropyl, H3C-[O-(CH2)2]2-, het-SO2NH-, Br-, N3-, or HO3S-(CH2)2-N(CH3)-C(O) -(CH2)6-C(O)-NH-; R6 is cyclopropyl, -CH3CH2 or t-butyl; R7 is -NR8SO2-het, -NR8SO2-phenyl optionally substituted with R9, -CH2-SO2phenyl optionally substituted with R9, or -CH2-SO2-het and R8 and R9 are as defined in the specification.
Patent NZ-518377-A (NZ)
Title: Preparation of diploid nucleus prior to transplantion into to enucleated oocyte in a method of nuclear transplantion ( cloning )
Inventor: RENARD JEAN-PAUL
IPC: C12N15/873
Filed: 2000-09-29
Abstract: Disclosed is the in vitro reconstitution of a non-human mammalian embryo, comprising treating the diploid nucleus of a somatic donor cell, before transfer to an enucleated oocyte, by controlled proteolysis of non-histone proteins, and induction of isomorphic swelling of the nucleus .
Patent NZ-521245-A (NZ)
Title: Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha
Inventor: DUAN JINGWU
IPC: C07D211/58
Filed: 2001-03-15
Abstract: A-amino acid derivatives of formula (I) are described, for which the substituents are defined herein. The derivatives are used in the manufacture of medicaments for use as matrix metalloprotease inhibitors and TNF-alpha inhibitors.
Patent NZ-523932-A (NZ)
Title: Use of metal complexes containing perfluoroalkyl as contrast agents in MR-imaging for the representation of plaques, tumours and necroses
Inventor: PLATZEK JOHANNES
IPC: C07H15/26
Filed: 2001-07-23
Abstract: Disclosed is a method for MRl imaging comprising: conducting MRI imaging on a patient previously administered with an MRI contrast agent, wherein the contrast agent comprises a perfluoroalkyl-containing metal complex that has a critical micelle formation concentration <10-3 mol/l, a hydrodynamic micelle diameter (2 Rh)> 1 nm and a proton relaxivity in plasma (R1)>10 l/mmol×s, and wherein the uptake of contrast agent in tissue has been allowed, and visualizing plaque in which contrast agent is uptaken, or independently simultaneously visualizing necroses and tumors in which contrast agent is uptaken.
Patent NZ-524229-A (NZ)
Title: Method for simultaneous detection of many different methylation positions of specific cytosine residues in genomic DNA in the sequence context of 5'-CpG-3'
Inventor: OLEK ALEXANDER
IPC: C12Q1/68
Filed: 2001-09-01
Abstract: A method for detecting the degree of methylation of a defined cytosine in the sequence context 5'-CpG-3' of a genomic DNA sample is described. The first stage involves chemically treating the genomic DNA in such a way that the cytosine bases, but not the 5-methylcytosine bases, are converted into uracil. Parts of the genomic DNA containing the defined cytosine are then amplified. The amplified parts are given a detectable label and the extent of the hybridisation of the amplified parts on the two classes of oligonucleotides is then determined by detecting the label in the amplified parts. The degree of methylation of the defined cytosine in the genomic DNA sample can be deduced on the basis of the relationship between the labels detected on the two classes of oligonucleotides following the hybridisation.
Patent NZ-525142-A (NZ)
Title: Method for isolating etidronate disodium
Inventor: GRAWE DETLEF
IPC: C07F9/38
Filed: 2001-09-28
Abstract: A method for isolating etidronate disodium is disclosed, wherein (a) a liquid-liquid dispersion consisting of an aqueous-organic phase and an aqueous phase containing the etidronate disodium salt is set to a temperature of between 0 °C and 30 °C and is intensively mixed; (b) a coarse-grained fraction is subsequently precipitated out of the liquid-liquid dispersion and; (c) in a second, delayed step, a fine-grained fraction is precipitated out of the organic phase. The invention also relates to a novel solid form of etidronate disodium that can be obtained using this method. Etidronate disodium produced by this method has a particle size in the region of 0.2 to 1.0 mm, good flowability and a high bulk density, and is coupled with properties that can be pharmaceutically exploited.
Patent NZ-531674-A (NZ)
Title: Compositions and methods for the diagnosis and treatment of tumor
Inventor: FRANTZ GRETCHEN
IPC: A61K47/48
Filed: 2002-09-11
Abstract: Disclosed is the use of an antagonist of a tumor-associated antigenic target 179 (TAT 179) polypeptide of SEQ ID NO:93 in the manufacture of a medicament for inhibiting the growth of a cancer cell expressing said TAT 179 polypeptide, wherein the antagonist is selected from the group consisting of anti-TAT 179 antibodies and functional fragments thereof, functional fragments and variants of native TAT 179 polypeptides, peptides, antisense oligonucleotides, and small organic molecules.
Patent NZ-532561-A (NZ)
Title: Structural beam
Inventor: NEWMAN GERALD M
IPC: E04C3/20
Filed: 2002-09-26
Abstract: A method, and the resultant apparatus, for designing a fire resistant structural beam, such as a computer-aided design of a fabricated steel beam having an intumescent coating material, by obtaining a number of values for a number of physical parameters of the structural beam, including reading temperature information that comprise empirical information derived from heating a structural beam and a number of temperatures at a number of locations.
Patent NZ-539594-A (NZ)
Title: Manufacturing folded structures and sheet therefore with slits offset relative to desired bend lines
Inventor: DURNEY MAX W
IPC: D04H3/00
Filed: 2003-09-26
Abstract: A process is disclosed for designing and manufacturing precision-folded, high strength, fatigue-resistant structures and a sheet therefore. The techniques include methods for precision bending of a sheet of material (241) along a bend line (245) and a sheet of material formed with bending strap-defining structures, such as slits or grooves (243), are disclosed. Methods include steps of designing and then separately forming longitudinally extending slits or grooves (243) through the sheet of material in axially spaced relation to produce precise bending of the sheet (241) when bent along the bend line (245). The bending straps have a configuration and orientation which increases their strength and fatigue resistance, and most preferably slits or arcs are used which causes edges to be engaged and supported on faces (255) of the sheet material on opposite sides of the slits or arcs. The edge-to-face contact produces bending along a virtual fulcrum position in superimposed relation to the bend line (245). Several slit embodiments (243) suitable for producing edge-to-face engagement support and precise bending are disclosed, as is the use of the slit sheets to produce various three-dimensional structures and to enhance various design and fabrication techniques.
Patent NZ-543411-A (NZ)
Title: Paper machine fabric
Inventor: TAIPALE SEPPO
IPC: D21F1/00
Filed: 2004-06-29
Abstract: Disclosed is a paper machine fabric comprising at least two machine direction yarn systems (3, 4), which are bound together by means of a binding yarn system (5). The layer of the machine side is formed of a warp system (4) and a binding yarn system (3). The binding yarn system comprises a binding yarn (5), binding yarns or a pair of binding yarns. The binding yarn (5), the binding yarns or the pair of binding yarns is/are bound to more than one bottom warps (4) at the point where the binding yarn (5) binds the top and bottom warps together.
Patent NZ-543827-A (NZ)
Title: A sub-frame for supporting a bowl on a chassis, a mixer assembly including the sub-frame and a vehicle on which the mixer assembly is mounted
Inventor: PETRIE MARK
Filed: 2005-11-29
Abstract: A vehicle for supporting a load on a chassis is disclosed, with particular application to concrete transport trucks. A sub-frame of a support (13) lies across and is fixed to the chassis. A load support frame is pivotally mounted to the sub-frame, with the mounting permitting the load support frame to pivot relative to the sub-frame and chassis in the range of 1-20 degrees. This accommodates flexing of the chassis and reduces fatigue in the load carrying structure.
Patent NZ-544143-A (NZ)
Title: Ladder
Inventor: MANN JAMES LESLIE
IPC: E06C1/38
Filed: 2004-06-04
Abstract: A ladder (11) comprising a plurality of primary support members, in the form of rungs (15), releasably supported in spaced apart relation by at least one elongate element (13). The at least one elongate element comprises a plurality of secondary support members (17) adapted to slidingly engage each other in an end to end relationship to form the at least one elongate element. The sliding engagement of one secondary support member to an adjacent secondary support member releasably secures the primary support member relative to the at least one elongate element.
Patent NZ-544785-A (NZ)
Title: Antisense polynucleotides of canola deoxyhypusine synthase (DHS)
Inventor: THOMPSON JOHN E
IPC: C07K14/47
Filed: 2004-06-21
Abstract: Disclosed are antisense polynucleotides of canola deoxyhypusine synthase (DHS) wherein the DHS comprises the amino acid sequence SEQ ID NO: 71. Further disclosed are expression vectors containing such, and methods of inhibiting expression of DHS in a canola plant by expressing the antisense polynucleotide in at least one of its cells.
Patent NZ-556218-A (NZ)
Title: Processes for preparing 4-(phenoxy-5-methyl-pyrimidin-4-yloxy) piperidine-1-carboxylic acid derivatives and related compounds
Inventor: GHARBAOUI TAWFIK
IPC: C07D401/12
Filed: 2006-01-09
Abstract: Disclosed herein is a process for preparing an iodide salt compound of formula I, comprising of: reacting a compound of Formula II with a compound of Formula III in the presence of an iodide salt, wherein substituents are as defined within the specification. Also disclosed is a process for preparing a compound of Formula II by combining a compound of Formula IV with a compound of Formula V to form a mixture and then adding a base to said mixture to form a compound of Formula II.
Patent NZ-563071-A (NZ)
Title: Modified asphalt binder material using crosslinked crumb rubber and methods of manufacturing a modified asphalt binder
Inventor: MARTIN JEAN-VALERY
IPC: C08L95/00
Filed: 2006-05-03
Abstract: A modified asphalt binder composition is disclosed, which comprises: a. about 60% by weight to about 98.9% by weight asphalt binder material; b. about o. 1% by weight to about 30% by weight crumb rubber; c. about 0.05% by weight to about 5% by weight of at least one acid selected from the group consisting of phosphoric acid, polyphosphoric acid, sulfuric acid at more than 90% wt, boric acid, adipic acid, citric acid, oxalic acid, tartaric acid, maleic acid, valeric acid, succinic acid, fumaric acid, glutamic acid, phtalic acid, acetic acid, and combinations thereof; and d. about 0.01% by weight to about 5% by weight of a cross-linking agent. A method for making a modified asphalt binder composition is also disclosed, which comprises the steps of: a. providing neat asphalt in an appropriate vessel; b. heating the neat asphalt to a temperature of between about 120 Deg. C and about 200 Deg. C; c. adding to the neat asphalt between about 0.5% by weight and about 30% by weight crumb rubber; d. mixing the asphalt and the crumb rubber with one of a high shear mixer or a low shear mixer for a period of between about 5 minutes and about 10 hours; e. adding between about 0.01% by weight and about 5% by weight of a cross-linking agent; f. mixing the cross-linking agent and asphalt with one of a high shear mixer or a low shear mixer for a period of between about 5 minutes and about 10 hours; g. adding between about 0.05% by weight and about 5% by of at least one acid; and h. agitating the acid and asphalt with one of a high shear mixer or a low shear mixer for a period of between about 5 minutes and about 48 hours.
Patent NZ-564009-A (NZ)
Title: Mooring robot array control system and method therefore
Inventor: MONTGOMERY PETER JAMES
IPC: E02B3/20
Filed: 2007-12-04
Abstract: A mooting robot array control system is suitable for controlling at least one of a plurality of mooring robots for mooring a vessel to a terminal. The array control system (100) comprises: i) a proximity sensor associated with a mooring robot (150); ii) an engagement sensor and iii) instructions for directing a processor to process the proximity signal and the engagement signal to generate a processed signal which is indicative of whether the mooring robot is suitable for use in mooring the approaching vessel (200). The proximity sensor is capable of generating a proximity signal indicative of the proximity of a vessel approaching the mooting robot. The engagement sensor is configured for sensing whether the same mooring robot is engaged with a vessel, and capable of generating an engagement signal in accordance with the sensed result. The array control system can further include the processor and the receiving means for i) receiving the engagement signal from the engagement sensor, or ii) receiving the proximity signal from the proximity sensor; or iii) receiving both the engagement signal and the proximity signal. Further disclosed is a mooring robot array control system comprises receiving means and instructions for directing a processor. The receiving means receives an engagement signal from an engagement sensor that is configured for sensing whether a mooring robot is engaged with a vessel, and capable of generating an engagement signal in accordance with the sensed result; and receives a proximity signal from a proximity sensor that is associated with the same mooring robot, the proximity sensor being capable of generating a proximity signal indicative of the proximity of a vessel to the mooring robot. The instructions direct the processor to process the proximity signal and the engagement signal to generate a processed signal indicative of whether the particular mooring robot of the plurality of mooring robots is suitable for use to moor a vessel.
Patent NZ-572368-A (NZ)
Title: Method and compositions for treating hematological malignancies
Inventor: CHONG LEE S
IPC: A61K31/00
Filed: 2007-05-16
Abstract: Disclosed is an organic acid salt of the compound of formula (I) or its tautomers and solvates. Also disclosed is the use of the above mentioned organic salt for preparing a pharmaceutical composition for treating neoplasm or haematological malignancy.
Patent NZ-576812-A (NZ)
Title: Humanized anti-factor d antibodies
Inventor: WU HERREN
IPC: A61P37/00
Filed: 2007-10-31
Abstract: Provided is a murine anti-Factor D antibody or antibody fragment thereof having potent haemolytic inhibition activity, comprising specified six CDRs or specified heavy and light chain variable domains. The antibody can be used to treat various complement mediated disorders.
Patent NZ-577577-A (NZ)
Title: Process for conversion of biomass to fuel
Inventor: ROBERTS WILLIAM L
IPC: C10G47/00
Filed: 2007-11-30
Abstract: Disclosed is a process for the direct conversion of lipidic biomass to a transportation fuel, said process comprising: (A) performing thermal hydrolysis on a lipidic biomass to form a product stream comprising a free fatty acid and form a by-product stream comprising glycerol; (B) performing catalytic deoxygenation on the free fatty acid stream to form a product stream comprising an n-alkane; and (C) performing one or more reforming steps on the n-alkane stream to form a product stream comprising a mixture of hydrocarbon compounds selected from the group consisting of n-alkanes, isoalkanes, aromatics, and cycloalkanes; wherein, after step (C), the hydrocarbon compounds in the product stream form an overall composition useful as the transportation fuel.